ArticleIndian journal of surgical oncology2024

Rechallenge of Trastuzumab-based Therapy in HER2-Positive Breast Cancer Patients who Progressed Under TDM-1.

Izzet Dogan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.